CD38 and plasma cell myeloma: The causes of resistance to anti-CD38 MoAbs are categorized into decreased or loss of CD38 expression, neutralization of CD38, and decreased immunological effects, including ADCC, CDC, and ADCP, via reduced numbers of NK cells, complement inhibitory proteins, and CD47 expression on myeloma cells, respectively [145].